ANTI-TUMOR ACTIVITY AND CARDIAC TOXICITY OF 4'-DEOXYDOXORUBICIN (4'-DEOXYDX) IN MICE

被引：0
|
作者：
CASAZZA, AM
BELLINI, O
SAVI, G
DIMARCO, A
机构：
[1] NATL TUMOR INST,MILANO,ITALY
[2] FARMITALIA,CARLO ERBA RES LABS,I-20146 MILAN,ITALY
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1981年 / 22卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [31] LIPOSOMES AS INVIVO CARRIERS OF ADRIAMYCIN - REDUCED CARDIAC UPTAKE AND PRESERVED ANTI-TUMOR ACTIVITY IN MICE
    GABIZON, A
    DAGAN, A
    GOREN, D
    BARENHOLZ, Y
    FUKS, Z
    CANCER RESEARCH, 1982, 42 (11) : 4734 - 4739
  • [32] Synthesis and Anti-tumor Activity of Novel Quinazolin-4-one Derivatives
    Sun, Jiajing
    Zhou, Likai
    Tan, Guanhui
    Wang, Shuxia
    Chen, Hua
    Li, Xiaoliu
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2017, 37 (02) : 455 - 461
  • [33] MURINE INTERLEUKIN-4 DISPLAYS POTENT ANTI-TUMOR ACTIVITY INVIVO
    TEPPER, RI
    PATTENGALE, PK
    LEDER, P
    CELL, 1989, 57 (03) : 503 - 512
  • [34] Novel eIF4A1 inhibitors with anti-tumor activity in lymphoma
    Kayastha, Forum
    Herrington, Noah B.
    Kapadia, Bandish
    Roychowdhury, Anirban
    Nanaji, Nahid
    Kellogg, Glen E.
    Gartenhaus, Ronald B.
    MOLECULAR MEDICINE, 2022, 28 (01)
  • [35] SYNTHESIS AND ANTI-TUMOR ACTIVITY OF 4'-O-METHYLDAUNORUBICIN, 4'-O-METHYLADRIAMYCIN, AND THEIR 4'-EPI ANALOGS
    CASSINELLI, G
    RUGGIERI, D
    ARCAMONE, F
    JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (02) : 122 - 123
  • [36] The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFNγ
    Paradis, TJ
    Floyd, E
    Burkwit, J
    Cole, SH
    Brunson, B
    Elliott, E
    Gilman, S
    Gladue, RP
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001, 50 (03) : 125 - 133
  • [37] The role of regulatory T cells in the anti-tumor activity of anti-CTLA-4 antibodies
    Thierry, Kevin
    Menetrier-Caux, Christine
    M S-MEDECINE SCIENCES, 2020, 36 (01): : 73 - 76
  • [38] The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFNγ
    Timothy J. Paradis
    Eugenia Floyd
    Jeff Burkwit
    Susan H. Cole
    Brandon Brunson
    Eileen Elliott
    Steven Gilman
    Ronald P. Gladue
    Cancer Immunology, Immunotherapy, 2001, 50 : 125 - 133
  • [39] In vitro and in vivo anti-tumor activity of alectinib in tumor cells with NCOA4-RET
    Arai, Sachiko
    Kita, Kenji
    Tanimoto, Azusa
    Takeuchi, Shinji
    Fukuda, Koji
    Sato, Hiroshi
    Yano, Seiji
    ONCOTARGET, 2017, 8 (43) : 73766 - 73773
  • [40] ANTI-TUMOR ACTIVITY OF A NEW ANTI-TUMOR ANTIBIOTIC, STUBOMYCIN
    KOMIYAMA, K
    EDANAMI, KI
    YAMAMOTO, H
    UMEZAWA, I
    JOURNAL OF ANTIBIOTICS, 1982, 35 (06): : 703 - 706
12345